STUDY OBJECTIVES: Mandibular repositioning appliance (MRA) therapy is a treatment option for patients with mild to moderate sleep apnea and for patients who do not tolerate continuous positive airway pressure. Titration of MRAs consists of sequential mandibular advancement guided by symptom improvement. The goal of the study was to determine if patients with an elevated apnea hypopnea index (AHI), despite the use of a subjectively optimized MRA, could achieve better results with additional titration during polysomnography (PSG). METHODS: Patients were enrolled if they had an AHI > or = 15/h and were referred for MRA therapy. The MRAwas advanced until symptoms improved. During the PSG, the technologist monitored the patient's sleep and increased mandibular protrusion until the AHI was improved. RESULTS: There was a significant improvement in AHI, minimum oxygen saturation, and total sleep time with the MRA before further advancement. At the final PSG, 65.2% of patients had an AHI < or = 10 associated with at least a 50% reduction in AHI. The incomplete responders had their appliance further titrated, and this improved the results of MRA therapy by 30.4% to a total success rate of 95.6%. CONCLUSIONS: This study shows that it is possible to improve the results of MRA therapy by further advancing the appliance during a titration PSG in patients with an incomplete response. The titration night improved the results of the usual clinical advancement of the MRA with substantially more patients achieving a successful outcome.
STUDY OBJECTIVES: Mandibular repositioning appliance (MRA) therapy is a treatment option for patients with mild to moderate sleep apnea and for patients who do not tolerate continuous positive airway pressure. Titration of MRAs consists of sequential mandibular advancement guided by symptom improvement. The goal of the study was to determine if patients with an elevated apnea hypopnea index (AHI), despite the use of a subjectively optimized MRA, could achieve better results with additional titration during polysomnography (PSG). METHODS:Patients were enrolled if they had an AHI > or = 15/h and were referred for MRA therapy. The MRAwas advanced until symptoms improved. During the PSG, the technologist monitored the patient's sleep and increased mandibular protrusion until the AHI was improved. RESULTS: There was a significant improvement in AHI, minimum oxygen saturation, and total sleep time with the MRA before further advancement. At the final PSG, 65.2% of patients had an AHI < or = 10 associated with at least a 50% reduction in AHI. The incomplete responders had their appliance further titrated, and this improved the results of MRA therapy by 30.4% to a total success rate of 95.6%. CONCLUSIONS: This study shows that it is possible to improve the results of MRA therapy by further advancing the appliance during a titration PSG in patients with an incomplete response. The titration night improved the results of the usual clinical advancement of the MRA with substantially more patients achieving a successful outcome.
Authors: Boris Pételle; Gerard Vincent; Frédéric Gagnadoux; Dominique Rakotonanahary; Bernard Meyer; Bernard Fleury Journal: Am J Respir Crit Care Med Date: 2002-04-15 Impact factor: 21.405
Authors: Willis H Tsai; Juan-Carlos Vazquez; Tsutomu Oshima; Leslie Dort; Brian Roycroft; Alan A Lowe; Eric Hajduk; John E Remmers Journal: Am J Respir Crit Care Med Date: 2004-04-22 Impact factor: 21.405
Authors: Christopher J Lettieri; Nathalie Paolino; Arn H Eliasson; Anita A Shah; Aaron B Holley Journal: J Clin Sleep Med Date: 2011-10-15 Impact factor: 4.062
Authors: M Dieltjens; O M Vanderveken; D Van den Bosch; K Wouters; J Denollet; J A Verbraecken; P H Van de Heyning; M J Braem Journal: Sleep Breath Date: 2012-11-13 Impact factor: 2.816
Authors: Ali A El-Solh; Gregory G Homish; Guy Ditursi; John Lazarus; Nithin Rao; David Adamo; Thomas Kufel Journal: J Clin Sleep Med Date: 2017-11-15 Impact factor: 4.062